BHVN stock news

NEW HAVEN, Conn., Jan. 31, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced the appointment of Michael Heffernan to its Board of Directors ("Board"). Mr. Heffernan is a seasoned biopharmaceutical leader with over 25 years of commercial… Read more
Investors need to pay close attention to Biohaven Pharmaceutical (BHVN) stock based on the movements in the options market lately. Read more
NEW HAVEN, Conn., Jan. 29, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical‑stage biopharmaceutical company with a portfolio of innovative, late‑stage product candidates targeting neurological diseases, including rare disorders, today announced… Read more
NEW HAVEN, Conn., Aug. 8, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN, the "Company"), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today… Read more
NEW HAVEN, Conn., Dec. 6, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today announced… Read more
NEW HAVEN, Conn., Nov. 5, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today announced that it… Read more
11/04/2019 Kleo Pharmaceuticals Appoints Thomas J. Lynch, Jr., MD, as Chairman of the Board - Kleo Pharmaceuticals, Inc., a unique immuno-oncology company developing… | November 4, 2019 Read more
NEW HAVEN, Conn., Oct. 28, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurologic and neuropsychiatric diseases, today announced that it… Read more
Biohaven Pharmaceutical (BHVN) needs investors to pay close attention to the stock based on moves in the options market lately. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on May 16) Adverum Biotechnologies Inc (NASDAQ: ADVM )(announced lifting of FDA's partial clinical hold on the second cohort of Phase 1 study of its wet age-related macular degeneration drug) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Fate Therapeutics Inc (NASDAQ: FATE ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Masimo Corporation (NASDAQ: MASI )(received FDA nod for Radius PPG, a tetherless sensor solution) MediciNova, Inc. (NASDAQ: MNOV ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) TransMedics Group Inc (NASDAQ: TMDX ) Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 16) Auris Medical Holding Ltd (NASDAQ: EARS ) CELLECT BIOTECH/S ADR (NASDAQ: APOP )(announced exploration of strategic alternatives) Enochian Biosciences Inc (NASDAQ: ENOB ) NGM Biopharmaceuticals Inc (NASDAQ: NGM ) Nuvectra Corp (NASDAQ: NVTR )(announced departure of COO and CFO) Precision Therapeutics Inc (NASDAQ: AIPT )(reacted to its first-quarter results) Sellas Life Sciences Group Inc (NASDAQ: SLS ) (reacted to its first-quarter results) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Tonix … Read more

Uber Time (Stocks To Watch Podcast)

12:00pm, Sunday, 05'th May 2019
Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At

ROCKIT